Pembroke Management, LTD Care Dx, Inc. Transaction History

Pembroke Management, LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$41.2 - $73.6 $4.33 Million - $7.74 Million	-105,191 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$59.15 - $91.99 $3,726 - $5,795	-63 Reduced 0.06%	105,191 $6.67 Million
Q2 2021 Aug 11, 2021	SELL	$63.02 - $95.11 $60,121 - $90,734	-954 Reduced 0.9%	105,254 $9.63 Million
Q1 2021 May 06, 2021	BUY	$57.62 - $95.6 $1.5 Million - $2.48 Million	25,955 Added 32.34%	106,208 $7.23 Million
Q4 2020 Feb 05, 2021	BUY	$41.43 - $77.09 $3.32 Million - $6.19 Million	80,253 New	80,253 $5.81 Million

218

51.1M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.1B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Pembroke Management, LTD, based on Form 13F filings with the SEC.

Stay updated on Pembroke Management, LTD with notifications on news.